SIRT1-modified human umbilical cord mesenchymal stem cells ameliorate experimental peritoneal fibrosis by inhibiting the TGF-β/Smad3 pathway

Overview of attention for article published in Stem Cell Research & Therapy, August 2020

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter: 4 X users

patent: 1 patent

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 17 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

MESENCHYMAL STEM CELLS, ANTI-INFLAMMATORY AGENT AND THERAPEUTIC AGENT FOR NEUROLOGICAL…

Application WO-2022153996-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.